Tiziana Life Sciences looks to phase 1 trial for intranasal Alzheimer’s drug
Tiziana Life Sciences Ltd. says it plans to submit an investigational new drug (IND) application…
Tiziana Life Sciences Ltd. says it plans to submit an investigational new drug (IND) application…
Emergex Vaccines Holding Limited has formulated and confirmed the synthesis and assembly of a CD8+…
SMART102, a human T-lymphoid progenitor cell injection derived from cord blood using Smart Immune’s ProTcell…
Estrella Biopharma, Inc. and TradeUP Acquisition Corp. have entered into a definitive business combination agreement…
AmplifyBio has acquired select assets from PACT Pharma, Inc., a privately held biopharmaceutical company developing…
Marengo Therapeutics is advancing its lead TCR activator, STAR0602, into clinic following clearance of its…
The first patient has been dosed in a phase 2 trial looking at a drug…
A license agreement has been signed between Helsinn Group and Juniper Biologics further widening the…
Safety and efficacy results from phase 1 and 2 clinical trials looking at a Covid-19…
A type of blood cell cancer called angioimmunoblastic T-cell lymphoma (AITL) can develop as mutations…
The first patient has been enrolled on a study to trial a treatment for relapsed…
US-based Orca Bio, today announced Precision-T, its pivotal phase 3 study, is open, enrolling and…